Natriumoxybat Neuraxpharm (Sodium Oxybate)

Sodium Oxybate acts on the central nervous system to improve sleep architecture in patients with narcolepsy.

• Narcolepsy with cataplexy: reduces the frequency of cataplexy attacks and improves nighttime sleep quality.
• Excessive daytime sleepiness associated with narcolepsy: helps maintain wakefulness during the day.
• Disrupted nocturnal sleep in narcolepsy: promotes consolidated sleep periods at night.

• Sodium Oxybate binds to and activates GABA_B receptors in the brain, enhancing inhibitory neurotransmission. This modulation of GABAergic pathways leads to a re‑balancing of sleep stages, increasing slow‑wave sleep and reducing the occurrence of cataplexy episodes associated with narcolepsy.

Sodium Oxybate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: transient pain often occurring after dosing.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Vomiting: occasional expulsion of stomach contents.
• Insomnia: difficulty initiating or maintaining sleep.
• Decreased appetite: reduced desire to eat.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing requiring medical attention.
• Seizures: convulsive episodes that may be life‑threatening.
• Severe hypotension: marked drop in blood pressure leading to fainting.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Confusion or hallucinations: altered mental status requiring evaluation.

Before initiating therapy with Sodium Oxybate, several safety considerations should be observed.

• Avoid alcohol: concurrent use can potentiate central nervous system depression.
• Monitor respiratory function: patients with sleep‑disordered breathing require close observation.
• Adjust dose in renal impairment: reduced clearance may increase exposure.
• Do not discontinue abruptly: tapering is recommended to avoid rebound symptoms.
• Contraindicated in severe obstructive sleep apnea: risk of worsening breathing.
• Store at room temperature: keep in the original container, protect from moisture and light.

Sodium Oxybate can interact with other substances that depress the central nervous system or alter its metabolism.

Major Interactions (Avoid)

• Alcohol: additive sedative effect increasing risk of respiratory depression.
• Opioids: synergistic CNS depression that may be life‑threatening.
• Benzodiazepines: enhanced sedation and respiratory compromise.
• Other GABA_B agonists: excessive inhibitory signaling.
• CNS depressants (e.g., barbiturates, antihistamines): heightened sedation.

Moderate Interactions (Monitor Closely)

• Antidepressants (especially SSRIs): may affect sleep patterns.
• Antihypertensives: potential additive hypotensive effect.
• Anticonvulsants: possible alteration of seizure threshold.
• CYP enzyme modulators: may influence drug metabolism, requiring dose adjustment.